MONTAGU APHARMA CO-INVEST LP
LONDON

Hellopages » Greater London » Southwark » SE1 2AP

Company number LP016066
Status Active
Incorporation Date 11 June 2014
Company Type Limited Partnership
Address 2 MORE LONDON RIVERSIDE, LONDON, SE1 2AP
Home Country United Kingdom
Phone, email, etc

Since the company registration two events have happened. The last two records are Term changed. 3 LIMITED partners appointed. 1 LIMITED partner ceased to be LIMITED partner. Increase in contribution. A transfer of interests. LIMITED partner resigned:mpe (managing partner). LIMITED partner appointed:crescent mezzanine partners vi (cayman) L.P.. more partners available on image.; 1 general partner appointed, 1 LIMITED partner appointed and the total amount contributed is 10 gbp. General partner appointed:mpe (G.P. iv general partner) LIMITED. LIMITED partner appointed:mpe (managing partner) LIMITED. CERT12 ‐ . The most likely internet sites of MONTAGU APHARMA CO-INVEST LP are www.montaguapharmacoinvest.co.uk, and www.montagu-apharma-co-invest.co.uk. The predicted number of employees is 1 to 10. The company’s age is eleven years and five months. Montagu Apharma Co Invest Lp is a Limited Partnership. The company registration number is LP016066. Montagu Apharma Co Invest Lp has been working since 11 June 2014. The present status of the company is Active. The registered address of Montagu Apharma Co Invest Lp is 2 More London Riverside London Se1 2ap. .


MONTAGU APHARMA CO-INVEST LP Events

27 Jun 2014
Term changed. 3 LIMITED partners appointed. 1 LIMITED partner ceased to be LIMITED partner. Increase in contribution. A transfer of interests. LIMITED partner resigned:mpe (managing partner). LIMITED partner appointed:crescent mezzanine partners vi (cayman) L.P.. more partners available on image.
11 Jun 2014
1 general partner appointed, 1 LIMITED partner appointed and the total amount contributed is 10 gbp. General partner appointed:mpe (G.P. iv general partner) LIMITED. LIMITED partner appointed:mpe (managing partner) LIMITED.
  • CERT12 ‐